T: 01243 786993 | Contact

January 2018

January 23, 2018

Alzheimer’s Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK. Pfizer plans to refocus efforts away from dementia research and is a reminder of one of the barriers that stands in the way of bringing about the first life-changing treatment for dementia.

« Back to News